Zobrazeno 1 - 10
of 65
pro vyhledávání: '"J.-J. Raabe"'
Autor:
Jean-Baptiste Bour, Laurent Andreoletti, Vanessa Cottet, Jean-Louis Jouve, J.-J. Raabe, Elisabeth Monnet, Gérard Thiéfin, Samira Fafi-Kremer, Morgan Faivre, Séverine Valmary-Degano, Georges Herbein, François Habersetzer, Michel Doffoel, Brice Malve, Hélène Barraud, V. Di Martino, Evelyne Schvoerer, Jean-Pierre Bronowicki, Christine Binquet, C. Richou, Patrick Hillon
Publikováno v:
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Apr 2017, Amsterdam, Netherlands. 66 (1, supplement), pp.S559-S560, 2017, 〈http://www.sciencedirect.com/science/article/pii/S0168827817315349?via%3Dihub〉. 〈10.1016/S0168-8278(17)31534-9〉
The International Liver Congress 2017 — 52nd Annual meeting of the European Association for the Study of the Liver
The International Liver Congress 2017 — 52nd Annual meeting of the European Association for the Study of the Liver, Apr 2017, Amsterdam, Netherlands. Journal of Hepatology 66 (1), pp.S559-S560, 2017, Abstracts of The International Liver Congress 2017 — 52nd Annual meeting of the European Association for the Study of the Liver. 〈http://www.sciencedirect.com/science/article/pii/S0168827817315349?via%3Dihub〉
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Apr 2017, Amsterdam, Netherlands. Journal of Hepatology 66 (1, supplement), pp.S559-S560, 2017, Abstracts of The International Liver Congress 2017 — 52nd Annual meeting of the European Association for the Study of the Liver. ⟨10.1016/S0168-8278(17)31534-9⟩
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Apr 2017, Amsterdam, Netherlands. 66 (1, supplement), pp.S559-S560, 2017, 〈http://www.sciencedirect.com/science/article/pii/S0168827817315349?via%3Dihub〉. 〈10.1016/S0168-8278(17)31534-9〉
The International Liver Congress 2017 — 52nd Annual meeting of the European Association for the Study of the Liver
The International Liver Congress 2017 — 52nd Annual meeting of the European Association for the Study of the Liver, Apr 2017, Amsterdam, Netherlands. Journal of Hepatology 66 (1), pp.S559-S560, 2017, Abstracts of The International Liver Congress 2017 — 52nd Annual meeting of the European Association for the Study of the Liver. 〈http://www.sciencedirect.com/science/article/pii/S0168827817315349?via%3Dihub〉
International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Apr 2017, Amsterdam, Netherlands. Journal of Hepatology 66 (1, supplement), pp.S559-S560, 2017, Abstracts of The International Liver Congress 2017 — 52nd Annual meeting of the European Association for the Study of the Liver. ⟨10.1016/S0168-8278(17)31534-9⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38828c5fdf392456ad65b65d999e9cfb
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01665366
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01665366
Publikováno v:
La Revue de Médecine Interne. 32:341-346
Resume Propos La maladie de Wilson (MW) est une affection genetique rare liee a une surcharge en cuivre. Son pronostic est domine par l’atteinte hepatique et par les troubles neuropsychiatriques. Nous rapportons une serie de 19 observations. Patien
Autor:
Gérard Babany, P. Melin, A Pinta, Michèle Chevallier, Jean-Pierre Zarski, Nathalie Sturm, Corinne Bonny, Philippe Sogni, Stéphanie Rouanet, Alice Cheveau, Hervé Desmorat, J.-J. Raabe
Publikováno v:
Liver International. 30:1049-1058
Background The efficacy of a maintenance therapy in non-responder patients with chronic hepatitis C has been essentially evaluated by histological semiquantitative scores. Aim The aim was to evaluate the efficiency of 2 years of treatment with pegint
Autor:
Stanislas Pol, Dominique Larrey, Hélène Fontaine, Valérie Canva, A. Tran, Christophe Hézode, Armando Abergel, Yoann Barthe, Laurent Alric, Thong Dao, Pierre Attali, J.-M. Pawlotsky, Damien Lucidarme, Didier Samuel, Patrice Cacoub, S. Metivier, Thierry Poynard, Paul Calès, V. de Ledinghen, Véronique Loustaud-Ratti, M. Bourlière, Isabelle Rosa, Fabrice Carrat, Véronique Grando-Lemaire, Fabien Zoulim, V. Di Martino, C. Dufour, Ghassan Riachi, Pierre-Henri Bernard, Jean-Pierre Bronowicki, Isabelle Portal, Lawrence Serfaty, T. Fontanges, Patrick Marcellin, J.-J. Raabe, Dominique Guyader, Xavier Causse, Jean-Pierre Zarski
Publikováno v:
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S617--S618, 2015, ⟨10.1016/S0168-8278(15)30971-5⟩
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S617--S618, 2015, 〈10.1016/S0168-8278(15)30971-5〉
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S617--S618, 2015, ⟨10.1016/S0168-8278(15)30971-5⟩
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S617--S618, 2015, 〈10.1016/S0168-8278(15)30971-5〉
International audience; no abstract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840f79824fc9669e5a8f633c9d3de28d
https://univ-rennes.hal.science/hal-01162777
https://univ-rennes.hal.science/hal-01162777
Autor:
Christophe Hézode, Hélène Fontaine, Yves Benhamou, Jean-Pierre Bronowicki, P. Mathurin, Ventzislava Petrov-Sanchez, Jean-Pierre Zarski, J.-J. Raabe, J. Gournay, Véronique Loustaud-Ratti, V. de Ledinghen, Olivier Chazouillères, Jean-Claude Trinchet, Dominique Guyader, C. Dorival-Mouly, P. Nahon, Isabelle Rosa, S. Lucier, M. Bourlière, Dominique Larrey, François Raffi, Albert Tran, Patrick Marcellin, S. Metivier, Ghassan Riachi, Anne Minello, I. Hubert-Fouchard, Abou Diallo, Stanislas Pol, Fabien Zoulim, Fabrice Carrat, Laurent Alric, Didier Samuel, Xavier Causse
Publikováno v:
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S258--S259, 2015, 〈10.1016/S0168-8278(15)30149-5〉
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S258--S259, ⟨10.1016/S0168-8278(15)30149-5⟩
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S258--S259, 2015, 〈10.1016/S0168-8278(15)30149-5〉
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S258--S259, ⟨10.1016/S0168-8278(15)30149-5⟩
International audience; no abstract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed901e57dc424dc5e33597180a3eab1b
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01162711
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01162711
Autor:
Thierry Davion, Gilles Pelletier, J.-J. Raabe, Dominique Roulot, Lawrence Serfaty, Claude Masliah, Claire Van Lemmens, Frédéric Oberti, Xavier Causse, H. Labadie
Publikováno v:
Hepatology. 37:887-892
The aim of our multicenter study was to assess the efficacy of ursodeoxycholic acid (UDCA) on the survival of patients with alcohol-induced cirrhosis and jaundice. We included patients with histologically proven alcohol-induced cirrhosis and serum bi
Autor:
H. Desmorat, F Bloch, Jacques Izopet, Daniel Fischer, B Mesnard, Pierre-Henri Bernard, François Bailly, J.-P. Lagasse, P. Couzigou, C Sayada, P Chossegros, G Force, Xavier Causse, Jean-Louis Payen, Marie-France Saint-Marc Girardin, J.C. Barbare, D Trois Vallets, Jean-Dominique Poveda, JC Schmit, Alexandre Pariente, P Sogni, Jean-Pierre Zarski, Albert Tran, Gérard Babany, L. Bettan, A Gauthier, Y Bacq, Eveline Boucher, Puig P Laurent, JM Lang, C Douvin, R Olivares, C Housset, Nathalie Boyer, W Rozenbaum, J.-J. Raabe, C Van Lemmens, O Danne, F. Montestruc
Publikováno v:
Journal of Hepatology. 32:1003-1010
Background/Aim: The aim of this prospective study was to compare the response to alfa-interferon treatment of chronic hepatitis C in two groups of patients: coinfected with human immunodeficiency virus (HIV) (G I) or not (G II). Methods: One hundred
Autor:
J. Guechot, Ulrich Beuers, J. P. A. Zarski, Elie-Serge Zafrani, D. Vetter, R.E. Poupon, P. E. Queneau, Y. Chretien, Lawrence Serfaty, G. Thieffin, D. Larrey, M. F. St Marc Girardin, J. D. Grange, H. Mathiex-Fortunet, Gustav Paumgartner, Renée E. Poupon, A. M. Bonnand, Christian Trepo, J.-J. Raabe, J. P. Capron
Publikováno v:
Scandinavian journal of gastroenterology, 35(6), 642-649. Informa Healthcare
Ursodeoxycholic acid (UDCA) could potentiate the effect of interferon (IFN) in patients with chronic hepatitis C resistant to IFN. We compared the efficacy of IFN with that of a combination of IFN and UDCA. Patients were randomized to receive UDCA (1
Autor:
Frédéric Oberti, Solange Bresson-Hadni, Yannick Bacq, Armand Abergel, Maryline Baud, Jean-Marc Combis, François Bailly, Raphaëlle Barnoud, J.-J. Raabe, Vincent Leroy, Albert Tran, Anne Minello, Xavier Causse, Marianne Maynard-Muet, Jean-Pierre Zarski, Tariq Hicham, Suzanne Chousterman, Lynda Hamici, Marie‐France St Marc Girardin
Publikováno v:
Hepatology. 27:862-867
The purpose of this study is to compare a combination of interferon (IFN)-alpha2a (Roferon) + Tenoxicam with IFN-alpha2a alone in the treatment of chronic hepatitis C. This prospective, randomized double-blind study included 149 patients, all of whom
Autor:
Stanislas Pol, Thierry Poynard, Isabelle Rosa, Armand Abergel, Valérie Canva, Lawrence Serfaty, Véronique Loustaud-Ratti, Jean-Pierre Zarski, Cyrille Feray, Xavier Causse, Patrick Hillon, J.-J. Raabe, Fabien Zoulim, Christophe Hézode, Pierre Attali, Dominique Guyader, Hélène Fontaine, Pierre-Henri Bernard, Patrice Cacoub, Laurent Alric, Didier Samuel, Dominique Larrey, Céline Dorival, Albert Tran, Ventzislava Petrov-Sanchez, Marc Bourlière, Ghassan Riachi, Jean-Michel Pawlotsky, Patrick Marcellin, Fabrice Carrat, Véronique Grando-Lemaire, Sophie Metivier, Damien Lucidarme, Vincent Di Martino, Victor de Lédinghen, Thong Dao, Jean-Pierre Bronowicki, Yoann Barthe
Publikováno v:
Journal of Hepatology
Journal of Hepatology, 2013, 59 (3), pp.434-441. ⟨10.1016/j.jhep.2013.04.035⟩
Journal of Hepatology, Elsevier, 2013, 59 (3), pp.434-441. ⟨10.1016/j.jhep.2013.04.035⟩
Journal of Hepatology, 2013, 59 (3), pp.434-441. ⟨10.1016/j.jhep.2013.04.035⟩
Journal of Hepatology, Elsevier, 2013, 59 (3), pp.434-441. ⟨10.1016/j.jhep.2013.04.035⟩
International audience; Background & AimsIn phase III trials, the safety profile of triple therapy (pegylated interferon/ribavirin with boceprevir or telaprevir) seems to be similar in HCV treatment-experienced cirrhotic and non-cirrhotic patients, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67eb2d7add68bbbb85622ed278eb09d3
https://hal.univ-lorraine.fr/hal-01708037
https://hal.univ-lorraine.fr/hal-01708037